Information Provided By:
Fly News Breaks for May 19, 2016
JNJ
May 19, 2016 | 08:28 EDT
Leerink analyst Danielle Antalffy believes Johnson & Johnson is "well positioned" to accelerate its device business growth to in line with or better than her currently projected 5% CAGR over the 2015-2020 time-frame, with a broad product pipeline supplementing improving execution and a recover in end user market volumes. The analyst reiterates an Outperform rating and $125 price target on the shares.